Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:affiliatedWith |
non-depolarizing neuromuscular blocker
|
| gptkbp:antidote |
gptkb:neostigmine
gptkb:sugammadex |
| gptkbp:ATCCode |
gptkb:M03AC03
|
| gptkbp:brand |
vecuronium bromide
|
| gptkbp:CASNumber |
50700-72-6
|
| gptkbp:discoveredBy |
gptkb:Organon
|
| gptkbp:eliminationHalfLife |
65-75 minutes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Norcuron
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Organon
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
allergic reaction
hypotension respiratory depression |
| gptkbp:usedDuring |
surgical procedures
|
| gptkbp:usedFor |
muscle relaxation
|
| gptkbp:bfsParent |
gptkb:vecuronium
|
| gptkbp:bfsLayer |
6
|